- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
CYTOTOXIC GRANULES HOUSE POTENT PROAPOPTOTIC TOXINS CRITICAL FOR ANTIVIRAL RESPONSES |
109 |
et al., 1996b; Shi et al., 1997). The mannose phosphate receptor (MPR) was thought to constitute the main pathway for granzyme entry into the cytoplasm (Motyka et al., 2000). However, more recent work has demonstrated that free granzymes do not require MPR to enter the target cell (Trapani et al., 2003). It has also been shown that a maximum of only 20% of grB is mannose- 6 phosphorylated, indicating that MPR-independent pathways must exist (Bird et al., 2005). Other studies have suggested that grB is predominantly complexed with the proteoglycan, serglycin, and that the entire complex is taken up into endosomes of the target cell via the MPR pathway (Veugelers et al., 2004). Although still controversial, recent studies have provided evidence against this idea (Bird et al., 2005; Raja et al., 2005), and cells deficient in M6R expression were as efficiently killed by CLs through granzyme-mediated apoptosis as M6R expressing cells, indicating that whether complexed to serglycin or not, granzymes do not require the M6R to mediate target cell entry (Trapani et al., 2003). In the absence of receptor-mediated endocytosis, granzymes have been postulated to enter the cell through fluidphase endocytosis (Bird et al., 2005; Trapani et al., 2003). After internalization, grB remains trapped in endocytic vesicles and cannot exert its apoptotic effects unless perforin or another pore-forming toxin is also present (Browne et al., 1999; Froelich et al., 1996b).
More recently, a direct role for perforin in grB entry into the target cell was proposed. Sublytic perforin levels caused calcium influx into the target cell, which triggered membrane repair and coincided with the endocytosis of granzymes (Keefe et al., 2005). These results suggest a requirement for the synchronous application of both perforin and grB to mediate target cell apoptosis. This proposed “endosomolytic” function of perforin, although popular as a hypothesis, has as yet not been supported by significant evidence. The different mechanisms by which perforin may facilitate granzyme entry into the target cell are shown in Figure 10-1.
2.5. Activation of death pathways by granzymes
Once released inside the target cell, granzymes are capable of processing various intracellular substrates, resulting in cell death. Granzymes are serine proteases that belong to the chymotrypsin superfamily and share common characteristics with chymotrypsin-like enzymes (Henkart et al., 1987). One of the key features of serine proteases is a triad of conserved residues (histidine, aspartic acid, and serine) at their catalytic site (Kraut, 1977; Murphy et al., 1988). A total of 11 granzymes have been identified in mice (A-G, K, L, M, and N), but only 5
Table 10-2. Chromosomal localization of functional granzyme gene subsets
Chromosomal location |
Species |
Granzyme(s) |
|
|
|
“Tryptase” locus |
|
|
5q11-q12 |
Human |
A and K |
13D |
Mouse |
A and K |
“Chymase” locus |
|
|
14q11-q12 |
Human |
B and H |
14D |
Mouse |
B, C, D, E, F, G, L, and N |
“Metase” locus |
|
|
19p13.3 |
Human |
M |
10q21.2 |
Mouse |
M |
Note: The granzyme genes are distributed to three loci, with each subfamily constituting a broad type of substrate specificity, either trypsinlike (tryptase), chymotrypsin-like (chymase), or cleavage after methionine (metase) activity.
Source: This table is a modified version of (Trapani, 2001) and (Grossman et al., 2003).
exist in humans (A, B, H, K, and M). Granzymes in both humans and mice are grouped functionally and genetically on the basis of their genes, localizing to one of three chromosomal loci, as summarized in Table 10-2.
Granzymes have very specific substrate specificities and are clearly processing (nondegradative) enzymes. Some granzymes (grA, K) cleave at basic residues (lys, arg) and others at bulky nonpolar residues (phe, trp) and therefore have trypsin-like (“tryptase”) or chymotrypsinlike (“chymase”) activity, respectively. Similarly, specificity for asp residues (grB) or met residues (grM) results in “aspase” and “metase” activity, respectively. The disparate substrate specificity suggests that granzymes may trigger specific death pathways and/or possess quite different additional functions. A key emphasis in this chapter is to describe the biological substrate preferences of different granzymes directly resulting in cell death.
3. GRANULE-BOUND CYTOTOXIC PROTEINS
The components of the secretory granules present in the CL can be categorized according to their proposed functions (summarized in Table 10-3). Some of the granule components are discussed in greater detail below.
3.1. Perforin
As described above, perforin plays a critical role in CL biology, primarily through its ability to form a pore in lipid membranes. However, very little is known about the mechanism of perforin pore formation and the specific perforin domains involved in this process. This is due, at least in part, to difficulty in expressing significant
110 |
KATHERINE BARAN, ILIA VOSKOBOINIK, NIGEL J. WATERHOUSE, VIVIEN R. SUTTON, AND JOSEPH A. TRAPANI |
Figure 10-1. Several hypotheses have been proposed to explain how granzymes enter the target cell to mediate their cell death functions. Originally, a perforin pore was proposed to act as a conduit for granzyme entry
(1). Other experiments suggest that soluble granzymes or granzymes complexed with serglycin can enter the target cell via endocytosis through the M6R or alternative generic pathways (3). More recently, perforinmediated membrane damage has been proposed to trigger a membrane repair mechanism, which allows granzymes entry into the target cell via endocytosis (2). See Color Plate 10.
quantities of perforin for structural studies. No structure exists for perforin, and few assays that probe structure/function relationships have been devised. Human perforin is a 67-kDa protein and consists of 555 amino acids, including its 21-residue signal peptide. There are some predicted functional domains interspersed throughout the protein, which are based on a combination of direct comparisons with complement proteins, perforin peptide experiments, and more recent perforin mutagenesis studies.
The membrane-interacting domain of both complement and perforin is commonly referred to as the membrane attack complex/perforin domain (MACPF) because of sequence similarity and proposed functional homology (Kwon et al., 1989; Lowrey et al., 1989; Shinkai et al., 1988). Crystal structures of the first proteins containing a MACPF domain, human C8α (Hadders et al., 2007; Slade et al., 2008) and Plu-MACPF (a putative toxin synthesized by the bacterium Photorhabdus luminescens), have recently been solved (Rosado
CYTOTOXIC GRANULES HOUSE POTENT PROAPOPTOTIC TOXINS CRITICAL FOR ANTIVIRAL RESPONSES |
111 |
||||
|
|
|
|
|
|
|
Table 10-3. Protein constituents of the secretory granules of CL |
|
|
|
|
|
|
|
|
|
|
|
Granule components |
Putative function |
Reference |
|
|
|
|
|
|
|
|
|
Specialized function in cell death |
|
|
|
|
|
Perforin |
Pore formation, disruption of plasma |
(Masson and Tschopp, 1985; Podack et al., 1985) |
||
|
|
membranes, and mediator of granzyme entry |
|
|
|
|
|
into target cell |
|
|
|
|
Granzymes |
Serine proteases with various substrate |
(Masson et al., 1986; Masson and Tschopp, 1987; |
||
|
|
specificities. Involved in caspase-dependent |
Pasternack et al., 1986) |
|
|
|
|
and independent cell death. |
|
|
|
|
Granulysin (human only) |
Microbicidal agent. Disruption of eukaryotic |
(Jongstra et al., 1987) |
|
|
|
|
and prokaryotic membranes and promoter of |
|
|
|
|
|
mitochondria-mediated apoptosis. |
|
|
|
|
Lysosomal hydrolases |
|
|
|
|
|
H+ ATPase |
Granule acidification |
(Kataoka et al., 1994) |
|
|
|
Cathepsins B & D |
Lysosomal cysteine proteases |
(Burkhardt et al., 1990; Peters et al., 1991) |
|
|
|
Cathepsin C |
Activation of granzymes by cleavage of |
(McGuire et al., 1993) |
|
|
|
(dipeptidylpeptidase I) |
N-terminal dipeptide |
|
|
|
|
-glucosidase |
Lysosomal enzyme |
(Burkhardt et al., 1990) |
|
|
|
arylsulphatase |
Lysosomal enzyme |
(Hargrove et al., 1993; Tschopp and Nabholz, |
|
|
|
|
|
1990) |
|
|
|
-glucuronidase |
Lysosomal enzyme |
(Orye et al., 1984) |
|
|
|
-hexosamidase |
Lysosomal enzyme |
(Tschopp and Nabholz, 1990) |
|
|
|
Lysosomal membrane component |
|
|
|
|
|
FasL |
Death receptor-mediated apoptosis |
(Kojima et al., 2002) |
|
|
|
CD63 |
Costimulatory element promoting sustained |
(Peters et al., 1991) |
|
|
|
|
T-cell activation and expansion |
|
|
|
|
Lamp-1 & Lamp-2 |
Lysosomal membrane proteins |
(Peters et al., 1991) |
|
|
|
Mannose-6-phosphate |
Granzyme tra cking within the CL |
(Burkhardt et al., 1990) |
|
|
|
receptor |
|
|
|
|
|
Structural component |
|
|
|
|
Proteoglycan (chondroitin |
Large negatively charged storage and carrier |
sulfate A) |
molecule for basic proteins |
Calreticulin |
Calcium binding and chaperone protein of the |
|
ER. Role in conjugate formation between |
|
e ector and target cells. |
(MacDermott et al., 1985; Stevens et al., 1989; Stevens et al., 1987)
(Dupuis et al., 1993)
Other |
|
|
TIA-1 and TIAR |
mRNA binding, stress monitor |
(Anderson et al., 1990; Kedersha et al., 1999) |
Leukophysin |
Granule tra cking |
(Abdelhaleem et al., 1996) |
et al., 2007; Rosado et al., 2008). Crucially, the structural data revealed homology with cholesterol-dependent cytolysins (CDCs), a large family of bacterial poreforming toxins whose molecular mechanism is better understood. CDCs do not possess alpha helices capable of membrane spanning, but instead are thought to form a “pre-pore” before insertion to enable membraneinteracting domains to be revealed (Dang et al., 2005; Tilley et al., 2005). This mechanism of pore formation sees polymerization occurring after membrane binding and before membrane insertion. Based on the high degree of structural similarity predicted between perforin and these toxins, further studies are warranted to
determine whether perforin also inserts into membranes via a similar mechanism.
3.2. Granulysin
Granulysin is a cytolytic member of the saposin-like family of lipid-binding proteins (Clayberger and Krensky, 2003; Munford et al., 1995). Mice do not have a granulysin gene, and this cationic molecule is only present in the secretory granules of human CLs. It has lytic activity against various microbes, including Gram-positive and -negative bacteria, fungi, and parasites (Pena and Krensky, 1997). Granulysin has also been speculated to